: RIAs generally charge a flat fee or a percentage of Assets Under Management (AUM) rather than earning commissions on trades. 3. Regulatory Impact Analysis (Public Policy) Regulatory Impact Analyses (RIA) - FDA
: It is used for hormone level measurement, drug monitoring (TDM), cancer detection through tumor markers, and allergy testing. R.I.A.()
: While still a benchmark for sensitivity, it has largely been replaced by non-radioactive methods like ELISA due to the safety and disposal challenges of radioactive materials. 2. Registered Investment Advisor (Finance) : RIAs generally charge a flat fee or
: They are typically registered with the SEC or state regulators (in the US) or SEBI (in India). : While still a benchmark for sensitivity, it
: It uses competitive binding , where a known amount of radiolabeled antigen competes with unlabeled antigen from a patient's sample for a limited number of antibody binding sites.
The acronym most commonly refers to Radioimmunoassay , a highly sensitive laboratory technique used to measure concentrations of substances like hormones or vitamins. However, depending on the context, it can also represent financial, regulatory, or technical terms. 1. Radioimmunoassay (Science & Medicine)
Developed in the late 1950s by Solomon Berson and Rosalyn Yalow, RIA revolutionized medical diagnostics by allowing the measurement of minute quantities of antigens (like insulin) in the blood.